+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Osteochondromas Drug"

From
Osteochondromas - Epidemiology Forecast - 2032 - Product Thumbnail Image

Osteochondromas - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Multiple Osteochondromas (MO) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Multiple Osteochondromas (MO) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Osteochondromas are a type of benign bone tumor that can occur in any bone, but most commonly affect the long bones of the arms and legs. They are most common in children and adolescents, and can cause pain, deformity, and difficulty with movement. Treatment for osteochondromas typically involves surgical removal of the tumor, and in some cases, chemotherapy or radiation therapy may be used. The osteochondromas drug market is a subset of the oncology drug market, and includes drugs used to treat osteochondromas. These drugs are typically used to reduce pain, reduce tumor size, and prevent recurrence. Common drugs used to treat osteochondromas include bisphosphonates, calcitonin, and denosumab. Some companies in the osteochondromas drug market include Novartis, Pfizer, Merck, and Amgen. Show Less Read more